Cvd Equipment Corp (CVV) Stock Analysis and Metrics

Cvd Equipment

NASDAQ: CVV

$7.09 ▼ -0.19 (-2.68%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap48.26 Mn

P/E-30.45

P/S1.87

Div. Yield0.00

ROIC (Qtr)-0.05

Total Debt (Qtr)181,000.00

Revenue Growth (1y) (Qtr)-33.23

Add ratio to table…

About

CVD Equipment Corporation designs, develops, and manufactures chemical vapor deposition, physical vapor transport, and thermal process equipment for the aerospace, compound semiconductor, semiconductor, battery energy storage, and advanced industrial markets as well as for research applications. The company is headquartered in Central Islip, New York, and operates a Stainless Design Concepts division in Saugerties, New York.

CVD Equipment Corporation generates revenue primarily through the sale of its chemical vapor deposition systems, physical vapor transport systems, thermal processing equipment, and ultra high purity gas and chemical delivery control systems. The company also provides process development support and collaborates with customers through its application laboratory to optimize performance.

The company operates through the following segments.

• CVD Equipment: This segment designs and manufactures chemical vapor deposition, physical vapor transport, and thermal process equipment targeting markets such as aerospace gas turbine engine components, high power electronics including silicon carbide and gallium nitride, and battery materials for energy storage.

• SDC: This segment designs and manufactures ultra high purity gas and chemical delivery control systems used in semiconductor fabrication, aerospace, solar cell production, LED manufacturing, carbon nanotube and nanowire processing, and various industrial applications.

CVD Equipment Corporation holds a strong position in the niche market of advanced deposition and thermal processing equipment, particularly as a leading supplier of preform chemical vapor infiltration and tow-coating systems for ceramic matrix composites used in next generation gas turbine jet engines. The company competes with larger international firms and smaller niche players, leveraging its 40 years of expertise, proprietary process control software, and application laboratory to deliver customized solutions and maintain a technological advantage.

The company serves aerospace and defense manufacturers, semiconductor wafer producers, battery material developers, universities, and research laboratories. Notable customers include Stony Brook University, which purchased 2 PVT150™ systems for its silicon carbide research center. A significant portion of revenue is derived from a limited number of large customers, though their specific names are not disclosed in the filing.

Investment Thesis

▲ Bull case

CVV's strategic divestiture of the SDC business to Atlas Copco Group for approximately $16.9 million in cash represents a significant catalyst that the market is underestimating, as it will generate net proceeds of roughly $15 million after expenses and taxes, substantially strengthening the balance sheet and providing financial flexibility to pursue higher-margin opportunities in the core CVD Equipment business. This transaction allows management to sharpen focus on the Central Islip, New York operations, where the company retains deep engineering expertise in chemical vapor deposition systems for advanced materials like silicon carbide on graphite and silicon carbide use in high-power electronics, which are critical for aerospace, defense, and emerging industrial applications. The proceeds, intended for initial investment in U.S. treasury securities, create a dry powder reserve that could be deployed toward acquisitions or internal R&D to enhance recurring revenue streams through service and spares, addressing a long-standing investor desire for less lumpy earnings. Furthermore, the workforce reduction in the CVD Equipment division, expected to save $1.8 million annually in 2026, combined with the shift to outsourced fabrication for certain components, will improve scalability and reduce fixed cost burdens, positioning the company to achieve operating leverage as order flow stabilizes. The retention of the Saugerties facility under a two-year lease to Atlas Copco also provides a steady, low-effort income stream without capital commitment, further supporting near-term profitability while management evaluates strategic alternatives for the core business.
Despite near-term revenue pressures, CVV's underlying demand fundamentals in key end markets remain robust and are being overlooked by investors fixated on quarterly volatility, particularly as 78% of historical orders stem from military and defense applications, including gas turbine engines and hypersonic ceramic materials research, which are supported by sustained U.S. government investment in next-generation aerospace technologies. The company's receipt of two PVT150 unit orders from Stony Brook University and ongoing gas delivery equipment demand in the SDC segment prior to divestiture indicate resilience in niche scientific and university research markets, which often counterbalance broader industrial softness. Management's acknowledgment of serving aerospace and defense as a key market, coupled with the shipment of a hypersonics research system in 2025, underscores exposure to high-growth, technologically advanced sectors where long-term funding cycles are less susceptible to temporary economic headwinds. Additionally, the improvement in gross margin to 28.3% in fiscal 2025—driven by the absence of a prior-year $1.6 million inventory write-down—reveals operational strengthening in the CVD Equipment segment that is not being fully appreciated, as it reflects better cost control and product mix even amid lower revenues. This margin expansion, combined with a strengthened balance sheet post-divestiture, suggests the company is closer to a profitability inflection point than current market pricing indicates, especially if order timing improves in the second half of 2026.
CVV's transformation strategy, including the exploration of strategic alternatives for certain businesses and product lines, holds unrecognized potential to unlock value beyond the SDC sale, as the Board has been evaluating options for several quarters with a focus on achieving smoother, more recurring revenue streams through service and spares—an objective explicitly acknowledged by management during the Q&A when discussing the desire for non-lumpy revenue cadence. The company's existing talent pool in engineering and technology, described as a full complement for CVD equipment development, represents a scalable asset that could be leveraged in acquisitions targeting adjacent technologies with stronger aftermarket potential, such as semiconductor equipment or advanced coating systems, where service revenue typically constitutes a higher percentage of total sales. The CFO's indication that proceeds will initially be invested in U.S. treasury securities implies a deliberate, low-risk approach to capital deployment, preserving flexibility to act quickly when attractive opportunities emerge, rather than rushing into suboptimal deals. This disciplined capital allocation, combined with the reduced fixed cost base from workforce reductions and outsourced fabrication, creates a scenario where even modest improvements in order flow could translate into disproportionate earnings gains due to operating leverage, a dynamic that is not yet reflected in the stock's valuation given the persistent focus on near-term revenue declines.

CVV's strategic divestiture of the SDC business to Atlas Copco Group for approximately $16.9 million in cash represents a significant catalyst that the market is underestimating, as it will generate net proceeds of roughly $15 million after expenses and taxes, substantially strengthening the balance sheet and providing financial flexibility to pursue higher-margin opportunities in the core CVD Equipment business. This transaction allows management to sharpen focus on the Central Islip, New York operations, where the company retains deep engineering expertise in chemical vapor deposition systems for advanced materials like silicon carbide on graphite and silicon carbide use in high-power electronics, which are critical for aerospace, defense, and emerging industrial applications. The proceeds, intended for initial investment in U.S. treasury securities, create a dry powder reserve that could be deployed toward acquisitions or internal R&D to enhance recurring revenue streams through service and spares, addressing a long-standing investor desire for less lumpy earnings. Furthermore, the workforce reduction in the CVD Equipment division, expected to save $1.8 million annually in 2026, combined with the shift to outsourced fabrication for certain components, will improve scalability and reduce fixed cost burdens, positioning the company to achieve operating leverage as order flow stabilizes. The retention of the Saugerties facility under a two-year lease to Atlas Copco also provides a steady, low-effort income stream without capital commitment, further supporting near-term profitability while management evaluates strategic alternatives for the core business.
Despite near-term revenue pressures, CVV's underlying demand fundamentals in key end markets remain robust and are being overlooked by investors fixated on quarterly volatility, particularly as 78% of historical orders stem from military and defense applications, including gas turbine engines and hypersonic ceramic materials research, which are supported by sustained U.S. government investment in next-generation aerospace technologies. The company's receipt of two PVT150 unit orders from Stony Brook University and ongoing gas delivery equipment demand in the SDC segment prior to divestiture indicate resilience in niche scientific and university research markets, which often counterbalance broader industrial softness. Management's acknowledgment of serving aerospace and defense as a key market, coupled with the shipment of a hypersonics research system in 2025, underscores exposure to high-growth, technologically advanced sectors where long-term funding cycles are less susceptible to temporary economic headwinds. Additionally, the improvement in gross margin to 28.3% in fiscal 2025—driven by the absence of a prior-year $1.6 million inventory write-down—reveals operational strengthening in the CVD Equipment segment that is not being fully appreciated, as it reflects better cost control and product mix even amid lower revenues. This margin expansion, combined with a strengthened balance sheet post-divestiture, suggests the company is closer to a profitability inflection point than current market pricing indicates, especially if order timing improves in the second half of 2026.
CVV's transformation strategy, including the exploration of strategic alternatives for certain businesses and product lines, holds unrecognized potential to unlock value beyond the SDC sale, as the Board has been evaluating options for several quarters with a focus on achieving smoother, more recurring revenue streams through service and spares—an objective explicitly acknowledged by management during the Q&A when discussing the desire for non-lumpy revenue cadence. The company's existing talent pool in engineering and technology, described as a full complement for CVD equipment development, represents a scalable asset that could be leveraged in acquisitions targeting adjacent technologies with stronger aftermarket potential, such as semiconductor equipment or advanced coating systems, where service revenue typically constitutes a higher percentage of total sales. The CFO's indication that proceeds will initially be invested in U.S. treasury securities implies a deliberate, low-risk approach to capital deployment, preserving flexibility to act quickly when attractive opportunities emerge, rather than rushing into suboptimal deals. This disciplined capital allocation, combined with the reduced fixed cost base from workforce reductions and outsourced fabrication, creates a scenario where even modest improvements in order flow could translate into disproportionate earnings gains due to operating leverage, a dynamic that is not yet reflected in the stock's valuation given the persistent focus on near-term revenue declines.

▼ Bear case

CVV's core CVD Equipment business continues to face structural demand challenges that the market may be underestimating, as evidenced by a 33% year-over-year and sequential decline in fourth-quarter 2025 revenue to $5 million, driven by softer demand, tariff-related uncertainties, reduced U.S. government spending for universities, and slower adoption in key end markets—factors that are not merely temporary but reflect deeper shifts in customer capital expenditure patterns and potential long-term funding constraints in academic and defense research sectors. The company's heavy reliance on two key customers, which accounted for 53% of fourth-quarter revenue and 41% of full-year 2025 revenue, creates significant concentration risk, especially as these relationships appear vulnerable to budget cycles and shifting priorities, with no clear diversification strategy articulated beyond general statements about serving aerospace and defense. Furthermore, the acknowledgment that bookings remain pressured by geopolitical uncertainty and tariff impacts suggests external macroeconomic headwinds that management cannot control, raising doubts about the sustainability of any near-term order recovery, particularly if university and government spending remains subdued beyond 2026.
Despite the positive gross margin improvement to 28.3% in fiscal 2025, this metric is misleading and potentially unsustainable, as it was primarily driven by the absence of a one-time $1.6 million inventory write-down from the prior year rather than genuine operational efficiency or pricing power, meaning the underlying profitability of the CVD Equipment segment remains fragile and highly sensitive to revenue fluctuations. The operating loss of $1.9 million for fiscal 2025, while slightly better than the $2.4 million loss in fiscal 2024, still reflects a business that is not generating sufficient gross profit to cover fixed costs, especially given that the improvement was offset by lower gross profit in the SDC and MesoScribe segments due to lower revenues—highlighting that the core business has not yet achieved a self-sustaining profitability threshold. Additionally, the $1.3 million noncash impairment charge in Q4 2025 related to outsourced fabrication transition costs indicates that the transformation strategy itself is incurring near-term expenses without guaranteed long-term savings, and the expected $1.8 million annual cost reduction from workforce cuts may not materialize fully if severance, transition, or rehiring costs erode the net benefit, leaving the company vulnerable to prolonged losses if order flow does not rebound meaningfully.
CVV's strategic pivot following the SDC divestiture carries significant execution risk, as the company has not identified any concrete acquisition targets or internal initiatives to deploy the approximately $15 million in net cash proceeds, with management explicitly stating they "do not have something that is material or a [path] yet" and that any strategic alternatives will take "the next few quarters" to identify, suggesting a lack of immediate vision for value creation beyond balance sheet strengthening. The reliance on investing proceeds in U.S. treasury securities implies a passive approach that may disappoint investors seeking active deployment of capital for growth, especially given the company's history of lumpy revenue and the absence of a clear path to recurring revenue streams through service and spares, despite management acknowledging this as a desired objective. Moreover, the decision to retain the Saugerties facility under a two-year lease to Atlas Copco, while providing modest income, does not resolve the underlying issue of excess capacity in the CVD Equipment business, and the continued focus on exploring divestitures or asset sales for other product lines signals ongoing uncertainty about the viability of the core operations, potentially leading to further value-eroding restructuring efforts if the transformation plan fails to stimulate sustainable demand recovery.

CVV's core CVD Equipment business continues to face structural demand challenges that the market may be underestimating, as evidenced by a 33% year-over-year and sequential decline in fourth-quarter 2025 revenue to $5 million, driven by softer demand, tariff-related uncertainties, reduced U.S. government spending for universities, and slower adoption in key end markets—factors that are not merely temporary but reflect deeper shifts in customer capital expenditure patterns and potential long-term funding constraints in academic and defense research sectors. The company's heavy reliance on two key customers, which accounted for 53% of fourth-quarter revenue and 41% of full-year 2025 revenue, creates significant concentration risk, especially as these relationships appear vulnerable to budget cycles and shifting priorities, with no clear diversification strategy articulated beyond general statements about serving aerospace and defense. Furthermore, the acknowledgment that bookings remain pressured by geopolitical uncertainty and tariff impacts suggests external macroeconomic headwinds that management cannot control, raising doubts about the sustainability of any near-term order recovery, particularly if university and government spending remains subdued beyond 2026.
Despite the positive gross margin improvement to 28.3% in fiscal 2025, this metric is misleading and potentially unsustainable, as it was primarily driven by the absence of a one-time $1.6 million inventory write-down from the prior year rather than genuine operational efficiency or pricing power, meaning the underlying profitability of the CVD Equipment segment remains fragile and highly sensitive to revenue fluctuations. The operating loss of $1.9 million for fiscal 2025, while slightly better than the $2.4 million loss in fiscal 2024, still reflects a business that is not generating sufficient gross profit to cover fixed costs, especially given that the improvement was offset by lower gross profit in the SDC and MesoScribe segments due to lower revenues—highlighting that the core business has not yet achieved a self-sustaining profitability threshold. Additionally, the $1.3 million noncash impairment charge in Q4 2025 related to outsourced fabrication transition costs indicates that the transformation strategy itself is incurring near-term expenses without guaranteed long-term savings, and the expected $1.8 million annual cost reduction from workforce cuts may not materialize fully if severance, transition, or rehiring costs erode the net benefit, leaving the company vulnerable to prolonged losses if order flow does not rebound meaningfully.
CVV's strategic pivot following the SDC divestiture carries significant execution risk, as the company has not identified any concrete acquisition targets or internal initiatives to deploy the approximately $15 million in net cash proceeds, with management explicitly stating they "do not have something that is material or a [path] yet" and that any strategic alternatives will take "the next few quarters" to identify, suggesting a lack of immediate vision for value creation beyond balance sheet strengthening. The reliance on investing proceeds in U.S. treasury securities implies a passive approach that may disappoint investors seeking active deployment of capital for growth, especially given the company's history of lumpy revenue and the absence of a clear path to recurring revenue streams through service and spares, despite management acknowledging this as a desired objective. Moreover, the decision to retain the Saugerties facility under a two-year lease to Atlas Copco, while providing modest income, does not resolve the underlying issue of excess capacity in the CVD Equipment business, and the continued focus on exploring divestitures or asset sales for other product lines signals ongoing uncertainty about the viability of the core operations, potentially leading to further value-eroding restructuring efforts if the transformation plan fails to stimulate sustainable demand recovery.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Specialty Industrial Machinery

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	GEV	GE Vernova Inc.	270.93 Bn	28.46	6.55	2.79 Bn
2	ETN	Eaton Corp plc	156.55 Bn	39.19	5.50	21.05 Bn
3	PH	Parker-Hannifin Corp	124.04 Bn	35.64	5.91	9.58 Bn
4	CMI	Cummins Inc	91.66 Bn	34.29	2.70	6.89 Bn
5	EMR	Emerson Electric Co	82.90 Bn	67.34	4.53	13.36 Bn
6	ITW	Illinois Tool Works Inc	81.54 Bn	26.02	5.03	9.15 Bn
7	AME	Ametek Inc/	55.40 Bn	36.26	7.29	2.18 Bn
8	ROK	Rockwell Automation, Inc	51.78 Bn	53.05	5.88	3.69 Bn

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password